Investigational Drug Information for PHA-793887
✉ Email this page to a colleague
What is the development status for investigational drug PHA-793887?
PHA-793887 is an investigational drug.
There have been 33 clinical trials for PHA-793887.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 4th 2020.
The most common disease conditions in clinical trials are Hereditary Angioedema Types I and II, Neoplasms, and Angioedemas, Hereditary. The leading clinical trial sponsors are National Cancer Institute (NCI), Nerviano Medical Sciences, and Pharvaris Netherlands B.V.
There are four US patents protecting this investigational drug and sixty-six international patents.
Summary for PHA-793887
| US Patents | 4 |
| International Patents | 66 |
| US Patent Applications | 45 |
| WIPO Patent Applications | 20 |
| Japanese Patent Applications | 11 |
| Clinical Trial Progress | Phase 3 (2020-02-04) |
| Vendors | 77 |
Recent Clinical Trials for PHA-793887
| Title | Sponsor | Phase |
|---|---|---|
| Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema | Pharvaris Netherlands B.V. | Phase 2/Phase 3 |
| Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II | Pharvaris Netherlands B.V. | Phase 2 |
| Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema | Pharvaris Netherlands B.V. | Phase 2 |
Clinical Trial Summary for PHA-793887
Top disease conditions for PHA-793887
Top clinical trial sponsors for PHA-793887
US Patents for PHA-793887
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| PHA-793887 | ⤷ Try a Trial | Generation of muscle lineage cells and therapeutic uses thereof | GENEA BIOCELLS USA (HOLDINGS), INC. (San Diego, CA) | ⤷ Try a Trial |
| PHA-793887 | ⤷ Try a Trial | Maturation of hepatocyte-like cells derived from human pluripotent stem cells | Takara Bio Europe AB (Gothenburg, SE) | ⤷ Try a Trial |
| PHA-793887 | ⤷ Try a Trial | Quaternary amine compounds and antibody-drug conjugates thereof | Genentech, Inc. (South San Francisco, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for PHA-793887
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| PHA-793887 | Australia | AU2017351638 | 2036-10-26 | ⤷ Try a Trial |
| PHA-793887 | Canada | CA3044691 | 2036-10-26 | ⤷ Try a Trial |
| PHA-793887 | China | CN110730819 | 2036-10-26 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
